...
首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Evaluation of N-(phenylmethyl)-4-(5-(phenylmethyl)-4,5,6,7-tetrahydro-1H-imidazo(4,5-c)p yridin-4-yl)benzamide inhibitors of Mycobacterium tuberculosis growth.
【24h】

Evaluation of N-(phenylmethyl)-4-(5-(phenylmethyl)-4,5,6,7-tetrahydro-1H-imidazo(4,5-c)p yridin-4-yl)benzamide inhibitors of Mycobacterium tuberculosis growth.

机译:结核分枝杆菌生长的N-(苯甲基)-4-(5-(苯甲基)-4,5,6,7-四氢-1H-咪唑并(4,5-c)对吡啶-4-基)苯甲酰胺抑制剂的评估。

获取原文
获取原文并翻译 | 示例
           

摘要

The biological evaluation of imidazopiperidines as FAS II inhibitors of Mycobacterium tuberculosis growth has been carried out with a view to assessment of potential as lead compounds for the development of a new TB drug. A summary of the hit evaluation and current challenges is described herein.
机译:已经进行了咪唑并哌啶作为结核分枝杆菌生长的FAS II抑制剂的生物学评估,目的是评估作为开发新型结核病药物的先导化合物的潜力。此处介绍了命中评估和当前挑战的摘要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号